Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) FCF Margin Growth (1y) (2010 - 2026)

Analysis

Haemonetics (HAE) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 194.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 984.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 641.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 66.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 119.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 1,788.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -177.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -395.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -473.00
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn 884.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 884.00
Mar 28, 2026 -1,514.00
Dec 27, 2025 1,562.00
Sep 27, 2025 2,108.00
Jun 28, 2025 1,408.00
Mar 29, 2025 1,381.00
Dec 28, 2024 1,462.00
Sep 28, 2024 -1,689.00
Jun 29, 2024 -1,350.00
Mar 30, 2024 2,114.00
Dec 30, 2023 -2,010.00
Sep 30, 2023 1,112.00
Jul 1, 2023 499.00
Apr 1, 2023 -1,684.00
Dec 31, 2022 181.00
Oct 1, 2022 773.00
Jul 2, 2022 550.00
Apr 2, 2022 1,691.00
Jan 1, 2022 -991.00
Oct 2, 2021 -50.00